Home Innovation That Matters

Innovation That Matters

Solid as a Rock: Creating a Strong Foundation for Developing First-in-Class Treatments to Fight Aggressive Cancers

By Rich Soll, Senior Vice President, Research Service Division, WuXi AppTec (@richsollwx) In the life sciences, disruptive innovation is no longer the exception; it’s the rule. One global R&D executive known for successfully driving innovation is Elaine Sullivan. Sullivan – who has 25 years of...

Harnessing Science for the Most Neglected Diseases

By Rich Soll, VP of Research Service Division at WuXi AppTec (@richsollwx)  “Some of these diseases are rapidly fatal, cause huge loss of life, and have a huge impact on people’s lives. Often these are diseases that have attracted little research and attention and certainly...

A Personal Journey in Creating Breakthrough Treatments for Disease

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) “As you toil and try to solve some scientific problems along the way, you’re so focused on solving some of these problems that you really don’t necessarily appreciate the impact that your work...

Inside Perspectives on European Biotech Venture Investment – An Interview with Forbion Capital’s Sander Slootweg

By Hui Cai, Vice President of Corporate Alliances and Head of Communications, WuXi AppTec “Since the late 1990’s there’s been a lot of change on the VC side in Europe. Those players that are still here have weathered the adverse market conditions of the past....

Metabomed: A New Venture in Israel’s Start-Up Ecosystem that Tackles Cancer’s Altered Metabolism

By Hui Cai, Vice President of Corporate Alliances and Head of Communications, WuXi AppTec “We want to understand deeply not only the impact of engaging a target that forms a synthetic lethal pair within the framework of a single cell assay, but also how that...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease...

We are thrilled about WuXi NextCODE's contribution of its artificial intelligence (AI) and sequencing teams to the discovery of a novel mechanism regulating how blood...